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ABSTRACT:The functional integrity of the intestinal epithelial barrier relies on tight coordinationof cell proliferation
andmigration,with failure to regulate theseprocesses resulting indisease. It is notknownwhether cell proliferation
is sufficient to drive epithelial cell migration during homoeostatic turnover of the epithelium. Nor is it known
precisely how villus cell migration is affected when proliferation is perturbed. Some reports suggest that pro-
liferation and migration may not be related while other studies support a direct relationship. We used established
cell-tracking methods based on thymine analog cell labeling and developed tailored mathematical models to
quantify cell proliferation andmigration under normal conditions andwhenproliferation is reduced andwhen it is
temporarily halted.We found that epithelial cellmigration velocities along the villi are coupled to cell proliferation
rateswithin the crypts inall conditions. Furthermore, haltingand resumingproliferation results in the synchronized
response of cell migration on the villi. We conclude that cell proliferation within the crypt is the primary force that
drives cellmigration along the villus. Thismethodology canbe applied to interrogate intestinal epithelial dynamics
and characterize situations in which processes involved in cell turnover become uncoupled, including pharmaco-
logical treatments and disease models.—Parker, A., Maclaren, O. J., Fletcher, A. G., Muraro, D., Kreuzaler, P. A.,
Byrne, H. M., Maini, P. K., Watson, A. J. M., Pin, C. Cell proliferation within small intestinal crypts is the principal
driving force for cell migration on villi. FASEB J. 31, 000–000 (2017). www.fasebj.org
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The epithelial lining of the intestine undergoes continual
renewal; adult stem cells at the base of intestinal crypts
proliferate and differentiate into multiple functionally
distinct epithelial subtypes,which thenmigrateupward to
the villus tips to eventually be shed into the gut lumen
(1, 2).Maintenanceof the functional integrityof the intestinal
epithelial barrier therefore requires tight coordination
of these processes, with failure to regulate epithelial cell
turnover resulting in cells’ escaping normal growth con-
trols, development of inflammatory disease, and tumor
formation.
In part because of current limitations impeding in vivo
imaging of entire crypt–villus units over prolonged pe-
riods, it is still not clear exactly how these processes are
interrelated. Passive mitotic pressure generated by cell
division in the intestinal crypts, and subsequent gradual
expansion in cell diameter along the crypt–villus axis,
provides aplausible explanation for the steady continuous
migration of epithelial cells (3, 4). Indeed, previous com-
putational models suggest that these forces alone are suf-
ficient to explain observed rates of cell migration, at least
within the crypt (5–10). Conversely, other studies have
reported continued epithelial cell migration or evidence
for villus-to-crypt feedback in regulating proliferation
rates when crypts were targeted with irradiation, ische-
mia, or cytotoxic agents (11–18). In addition, cellmigration
on the villus has been found to exhibit a circadian rhythm,
which is not observed in cell proliferation in the crypt (19).
Active migration processes, such as those seen during
wound healing (20–23), have been proposed to explain
apparent disparities between proliferation and migration
ABBREVIATIONS: Ara-C, cytosine arabinoside; BrdU, 5-bromo-29-deoxy-
uridine; CVEU, crypt–villus epithelial unit; DAB, 3,39-diaminobenzidine;
HRP, horseradish peroxidase; IdU, 5-iodo-29-deoxyuridine; pH3, phospho-
Histone 3
1 Current affiliation: Department of Engineering Science, University of
Auckland, Auckland, New Zealand.
2 Correspondence: Gut Health and Food Safety Research Programme,
Institute of Food Research, Colney, Norwich NR4 7UA, United King-
dom. E-mail: carmen.pin@ifr.ac.uk
This is an Open Access article distributed under the terms of the Creative
Commons Attribution 4.0 International (CC BY 4.0) (http://creativecommons.
org/licenses/by/4.0/) which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
doi: 10.1096/fj.201601002
This article includes supplemental data. Please visit http://www.fasebj.org to
obtain this information.
0892-6638/17/0031-0001 © The Author(s) 1
 The FASEB Journal article fj.201601002. Published online November 3, 2016.
 Vol.,  No. , pp:, November, 2016The FASEB Journal. 143.167.30.213 to IP www.fasebj.orgDownloaded from 
rates, whereas an alternative explanation for uncoupling
between crypt and villus cell migration is the contribution
of whole villus contraction and expansion (24, 25).
The purpose of this work was to investigate whether
cell proliferation within crypts is sufficient to explain the
observed cell migration on villi, both during homeosta-
sis and under altered conditions in which crypt cell pro-
liferation is either reduced or temporarily inhibited. To this
end,weused the thymineanalogs5-bromo-29-deoxyuridine
(BrdU) and 5-iodo-29-deoxyuridine (IdU), for tracking
proliferative cells and their descendants along the crypt
villus axis. BrdU, IdU, and similar thymine analogs are
incorporated into newly synthesized DNA of dividing
cells during the S phase (26, 27). The incorporated mole-
cule is transmitted todaughter cells, regardlessofwhether
they proliferate. If the exogenous administration of these
molecules is discontinued, the cell label content is di-
luted by each cell division and is no longer detected after
4–5 generations (28). To quantify cell proliferation and
migration, we have developed mathematical models to
describe the temporal dynamics of labeled cells across
the crypt villus axis.
Applying this methodology, we studied the relation-
ship between crypt cell production and villus cell migra-
tion in the proximal and distal small intestine of C57BL/6
mice; in transgenic Omomyc mice, which exhibit reduced
cell proliferation in the intestinal epithelium (29); and in
C57BL/6 mice treated with the cytostatic/cytotoxic agent
cytosine arabinoside (Ara-C) at doses that temporarily
halted cell proliferation.
MATERIALS AND METHODS
Animals
All animal experiments were conducted in accordance with the
Home Office Animals (Scientific Procedures) Act 1986.
Female C57BL/6 mice, aged 8–12 wk, were supplied by
Charles River (Margate, UnitedKingdom) andmaintained at the
University of East Anglia, United Kingdom. Male and female
TRE-Omomyc;actin-rtTA, mice, aged 8–13 wk, were kindly pro-
vided by Prof. Gerard Evans (Gurdon Institute, University of
Cambridge, United Kingdom). To induce omomyc expression,
we treated TRE-Omomyc;actin-rtTA mice with doxycycline de-
livered in thedrinkingwater (2mg/ml) commencing1wkbefore
the start of BrdU labeling.
Proliferative cell labeling and tissue processing
The thymine analogs 5-bromo-29-deoxyuridine (BrdU) and
5-iodo-29-deoxyuridine (IdU; both from Sigma-Aldrich,
Paisley, United Kingdom) were administered at 50 mg/kg
body weight by intraperitoneal injection. Time of day for
delivery was consistent across experiments, to reduce any
possible variation caused by proliferative circadian rhythms
(30). At appropriate time points thereafter, mice were eu-
thanized and intestinal tracts were removed, flushed, dis-
sected, and embedded and frozen in optimal cutting
temperature medium or fixed for 24 h in 10% neutral-
buffered formalin. Formalin-fixed tissues were then pro-
cessed through a xylene/alcohol series and embedded in
paraffin, and transverse sections of duodenum and ileum
were prepared at 5 mm.
Blocking proliferation using Ara-C
Mice were given an initial intraperitoneal injection of IdU 17 h
before a single injection of Ara-C (Sigma-Aldrich) at 250 mg/kg
body weight. Tissues were collected between 1 and 57 h there-
after,with BrdU administration 1 h before theywere euthanized,
at each time point.
Immunohistochemistry and immunofluorescence
Intestinal sections were deparaffinized before blocking en-
dogenous peroxidases by incubation in 1% H2O2 in metha-
nol, and heat-induced antigen retrieval in 10 mM citric acid
buffer (pH 6). BrdU- and IdU-labeled cells were detected
with sheep anti-BrdU-biotin or mouse anti-IdU (AbCam,
Cambridge, United Kingdom) followed by NeutrAvidin-
horseradish peroxidase (HRP; Thermo Fisher Scientific,
Loughborough, United Kingdom) or goat-anti-mouse-HRP
(Dako, Glostrup, Denmark) detected using 3,39-diaminobenzidine
(DAB; Dako) and counterstained with hematoxylin. Mitoses
were detected with rabbit monoclonal Ab (EPR17246) to his-
tone H3 (phospho-S10; AbCam). Expression of omomyc in in-
testinal crypts andvilliwasdetected, using rabbit anti-omomyc
antibody, goat anti-rabbit-HRP secondary, andDABdetection,
as above. Intestinal cryosections prepared at 5mmwere fixed in
acetone/methanol before incubation with primary antibodies
to BrdU (BU1/75-DyLight 550;Novus Biologicals, Abdingdon,
United Kingdom) and/or against IdU (mouse anti-IdU clone
32D8.D9; AbCam) followed by goat-anti-mouse Alexa 488
(Thermo Fisher Scientific).
Image acquisition and analysis
Images were acquired with a DMI-3000-B inverted microscope
andDFC-310-FX digital camera (Leica,Wetzlar, Germany), with
analysis performed in ImageJ software (National Institutes of
Health, Bethesda, MD, USA) (31).
Mathematical modeling and statistical analysis
A 2-compartment model of the temporal cell dynamics
of BrdU pulse-labeled cells in the crypt–villus epithelial
unit
We developed a time-dependent mathematical model of the
crypt–villus epithelial unit (CVEU) that distinguishes 2 physical
compartments: the crypt compartment, which includes all pro-
liferative cells in the CVEU and some nonproliferative cells, and
the villus compartment, which contains all remaining non-
proliferative cells.
We modeled the propagation of BrdU labeling across
these 2 compartments after a pulse of BrdU (Fig. 1A, B). After
BrdU injection, at the start of the experimental period, la-
beled cells were not homogenously distributed within the
crypt; they were more abundant in intermediate positions
and decreased in number toward the mouth and base of the
crypt; hence, the initial transfer of labeled cells from the crypt
to the villus compartment was negligible. This cell distribu-
tion changed as BrdU-labeled cells proliferated, differenti-
ated, and migrated so that nonproliferative BrdU-labeled
cells were generated within the crypt, the distribution of the
label became more homogenous, and the transfer of labeled
cells to the villus started. On the other hand, shedding of
labeled cells did not start until labeled cells reached the tip of
the villus.
We assume that, for our experimental conditions, the size of
the crypt compartment, NC, remains fixed at a constant value
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over time, and hence, cell proliferation within the crypt is com-
pensated for by the transfer of cells to thevillus and the rate of cell
proliferation is equal to the rate of cell transfer between com-
partments (see Fig. 1).
For simplicity, we assume that migration of labeled
cells from the crypt to the villus is initiated when the
number of labeled cells within the crypt reaches a thresh-
old value, LC*. Similarly, cell shedding from the villus is
initiated when the number of labeled cells in the villus
reaches a second threshold value, LV*. Other assumptions
are that 2 h after administration, BrdU is no longer avail-
able for uptake, and so, BrdU-labeled cells are generated
only by the division of previously labeled cells. Moreover,
we restricted our attention only to the period of time before
the cell BrdU content has been diluted below the detection
limit. With these assumptions, the temporal dynamics
of our model satisfy the ordinary differential equations
in Eq. 1:
dLC
dt
¼ dLCH

L*C2 LC

dLV
dt
¼ dLCH

LC2 LpC

2 gLVH

LV2 L*V
 (1)
whereLCandLVrepresent thenumberofBrdUlabeledcells in the
crypt and villus compartments, respectively, at time t; d(h21)
represents the specific cell proliferation rate within the crypt
and is equal to the specific rate of cell transfer between com-
partments. By cell proliferation we refer to the net difference
between cell proliferation and cell death; g(h21) is the rate of cell
shedding; and
HðxÞ ¼
 0 ifx# 01 ifx. 0
is the Heaviside step function.
For a label that progresses from the crypt to the villus
until labeled cells are shed from the tip of the villus, such that
g. 0 and LV. LV*, and imposing initial conditions LC (t0) =
LC0 and LV (t0) = LV0, the explicit solutions of Eq. 1 take the
form of Eq. 2:
LCðtÞ ¼ LC0edfðt2t0ÞþHðt2t1Þ½ðt12t0Þ2ðt2t0Þg
LVðtÞ ¼ LV0 þHðt 2 t1ÞHðt22 tÞLC0edðt12t0Þdðt 2 t1Þ þHðt 2 t2Þ
3

d
g
LC0edðt12t0Þ þ

LV0 þ LC0edðt12t0Þdðt22 t1Þ
2
d
g
LC0edðt12t0Þ

e2gðt2t2Þ2 LV0

(2)
where t1 and t2 are such that t2$ t1$ t0$ 0; they denote the
times at which the number of labeled cells within the crypt
and on the villus reach the threshold values LC* and LV*,
respectively.
If we restrict attention to the time before shedding of la-
beled cells starts (i.e., t, t2), then LV# LV* and Eq. 2 reduces
to Eq. 3:
LC ðtÞ ¼
 LC0e
dðt2t0Þ if t0# t # t1
LC0edðt12t0Þ if t . t1
LV ðtÞ ¼
 LV0 if t0# t # t1LV0 þ LC0edðt12t0Þdðt 2 t1Þ if t . t1
(3)
Eq. 2 andEq.3 canbe rearranged in termsofLC*andLV*,byusing
the following expressions (Eq. 4):
t1 ¼ t0 þ
ln

LpC

2 lnðLC0Þ
d
t2 ¼ t0 þ
ln

LpC

2 lnðLC0Þ
d
þ L
p
V2 LV0
dL*C
(4)
which are obtained by setting t= t1 and t= t2 in the expression for
LC and LV of Eq. 2, respectively.
Parameter estimation Our datawere collected before the
BrdU-labeled front reached the villus tip and shedding of
labeled cells started, and we therefore fitted Eq. 3 to the ob-
served counts of labeled cells in each compartment: crypt and
villus. The observed numbers of BrdU-labeled cells in the
crypt and villus compartments at each sampling time were
calculated as the sums of the proportions of BrdU-labeled
cells at all cell positions below and above the crypt–villus
boundary, respectively (Fig. 1). The crypt–villus boundary
which, as explained above, is equivalent to the size of the
crypt compartment,NC, was estimated as the lowest position
in the CVEU atwhich the proportion of BrdU-labeled cells 2 h
after BrdU injection is less than 0.01 (Table 1). We demon-
strate below and in Supplemental Fig. 2 that the crypt com-
partment, defined in this way, contains all proliferative cells
of the CVEU.
As explained in Results (Supplemental Fig. 1), experi-
mental “time 0” was set to 2 h after a single injection of a
thymine analogmolecule. In control andOmomycmice, both
t0 (initial time) and LV0 (initial number of labeled cells on the
villus) were given fixed values: t0 = LV0 = 0. For the dataset
collected within the first 0–10 h after Ara-C injection, the
prescribed value of t0 was 15 h, which corresponded to the
first sampling time after IdU label activation; for the dataset
collected beyond 10 h after Ara-C injection, t0 was fixed to
25 h, which accounted for the extra 10 h of arrested pro-
liferation. For both datasets derived from Ara-C-treated
mice, we assumed that the value of t1 (the time at which cell
transfer from crypt to villus starts) was equal to t0, reflecting
the fact that the IdU-labeled front was already on the villi at
t0. The remaining parameters in control and Omomyc mice,
t1, d (specific proliferation rate), and LC0 (initial number of
labeled cells in crypt), and in Ara-C-treated mice, d, LC0 and
LV0, were estimated by fitting Eq. 3 to the number of labeled
cells in each compartment, using the nonlinear regression
procedure of SAS 9.3 (SAS, Cary NC, USA). The function log
(L +1), where L is the number of labeled cells, was used for
variance homogenization purposes in the fitting process.
Supplemental Table 1 shows the fitting results for each ex-
perimental dataset.
Furthermore,we estimated the net cell production rate, in our
1-dimensional CVEU crypt compartment, by the product d · NC,
where d denotes the specific cell proliferation rate in our 2-
compartment model, and NC is the total number of cells, both
proliferative and nonproliferative, within the crypt. In that the
CVEUwehavedefined is a 1-dimensional columnof cells, the size
of the crypt compartment, NC, is equal to the position of the
crypt–villus boundary.
The velocity (cell lengths/h or cells/h) induced by mitotic
pressure of a cell located at any position x within the crypt, Vx,
was calculated as (Eq. 5):
Vx ¼
ðx
1
da dx ¼ d×x where da ¼
 d x#NC0 x.NC (5)
Thus, the velocity of a cell at the crypt–villus boundary is de-
terminedbyVC-V=d ·NC,which is also the cellmigrationvelocity
on thevillus related to crypt cell proliferation and is equivalent to
the crypt cell production rate defined above. We made the sim-
plifying assumption that the specific cell proliferation rate is
constant across cellpositions in thecryptandequal to theaverage
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Figure 1. BrdU pulse labeling of the CVEU. A) The CVEU, with numbers indicating the location of the ﬁrst few cell positions. B)
The 2-compartment model developed to quantify the temporal dynamics of BrdU labeling along the CVEU. C) Representative
(continued on next page)
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rate estimated for the entire crypt; however, the cell cycle dura-
tion seems to vary according to position, with longer cycles re-
ported at the base of the crypt than in the transit amplifying
compartment (2). Thus, the assumption of constant proliferation
rate across the crypt may increase the error of estimation of the
cell velocity at positions below the crypt–villus boundary.
We also estimated the time necessary for a cell to migrate
from the base of the crypt to the top of the villus as the sum
of the migration time within the crypt and the time to mi-
grate across the villus. The time required for a cell to migrate
from crypt base to the crypt–villus boundary can be calculated
as
ÐNC
1 1=Vxdx ¼ lnðNCÞ=d, where Vx = d · x is the velocity (cell
lengths/hour) of a cell at position x in the crypt, as described in
Eq. 5 and under the assumptions explained above. Assuming
that cell migration on the villus is driven by proliferation, the
time required for a cell to migrate from the crypt–villus
boundary to the tip of the villus results from dividing the
number of cells on the villus by the cell velocity at the villus–
crypt boundary, VC-V = d · NC, described above.
Evaluating the assumption that the defined crypt com-
partment contains all proliferative cells of the CVEU The
estimation of the location of the interface between the crypt
and villus compartments is based on the assumption that all
proliferative cells are located below a selected position which
is the lowest position of the CVEU at which the proportion of
labeled cells 2 h after BrdU injection is smaller than 0.01.
Failure of this assumption would result in erroneous estima-
tion of the absolute cell production in the crypt compartment
per hour, or cell velocity at the crypt–villus boundary, esti-
mated by VC-V = d · NC.
We have analyzed the sensitivity of the model parameters to
the position of the crypt–villus boundary. Todo that,we selected
several positions for the crypt–villus boundary above and below
our selected criterion using the dataset generated in the duode-
num of control mice and ileum of the Omomycmice. The model
was fitted to theobservednumberof labeled cells in the cryptand
villus compartment for each tested boundary. Similar absolute
cell production rates in the crypt were observed for positions of
the boundary equal to, or higher than, the position selected with
our criterion. A larger number of cells in the crypt compartment,
NC, resulted in compensatory reductions in the fitted values of
the specific cell proliferation rate, d, (Supplemental Fig. 1), dem-
onstrating that our selected crypt–villus boundary is above
practically all proliferative cells in the CVEU. Had proliferative
cells been located above the selected boundary, variable absolute
cell production rates would have been detected for boundaries
above our selected position.
Estimating cell velocity along the villus compartment from
BrdU labeling experiments
We defined the position of the labeled front as the distance in
micrometers from the base of the crypt to the location of the
highest BrdU-labeled cell on theCVEU. Figure 4 indicates that in
our 1-dimensional CVEU the displacement of the labeled front
along the villus takes place at constant velocity. Therefore, the
average observed velocity of the labeled front on the villus
compartment, VLF, (micrometers/hour) was estimated by linear
regression assuming (Eq. 6):
XLFðtÞ ¼ K þ VLFt ; (6)
whereXLF (t) is the position of the labeled front at time t, andK is
an arbitrary constant.
Statistical inference
The statistical comparison of crypt cell production rates inmouse
models and tissues was performed by simulating the posterior
probability distribution of the difference in the crypt cell pro-
duction rate between control mice and other mouse models and
between the duodenum and ileum.
We estimatedP[VC-V (group i).VC-V (group j) | X ],where
X denotes our dataset of observed number of labeled cells
across the CVEU over time, and i and j represent the mouse
model tissues in comparison, usingMonte Carlomethods.We
assumed that VC-V was the product of 2 variables d · NC with
known posterior probability distributions: d | X which fol-
lowed an inverse g distribution with parameters k and u and
NC | X, which had a log-normal distribution with parameters
m ands. The parameters of these distributions are known from
the fitted values and associated standard errors of d andNC for
each group of mice or tissues (Table 1). The number of simu-
lated values from each distributionwas 10,000,which enabled
the estimation of the average and error of the simulated ran-
dom variables with a precision of 3 significant figures. Dif-
ferences between groups were considered significant when P
[VC-V (group i) . VC-V (group j) | X] . 0.95 (see Fig. 2F,
Supplemental Fig. 3).
Similarly, we simulated the posterior probability of the
ratio between cell velocity at the crypt–villus boundary in-
duced by mitotic pressure, and cell velocity along the villus,
VC-V/VLF, for each mouse model tissue using Monte Carlo
methods. The posterior probability of VC-V was simulated as
described above; VLF | X was assumed to have a normal
distribution, with known parameters presented in Table 1 for
each tissue. The statistical comparison of the computed ratio
among the assayed mouse models and tissues was made by
simulating the 95% confidence interval of the difference be-
tween their ratios.
RESULTS
Development of a 2-compartment model of
temporal cell dynamics of BrdU pulse-labeled
cells in the CVEU
We defined the CVEU as a 1-dimensional column of
cells running from the base of a crypt to the tip of a
neighboring villus, as observed on transverse sections
of the small intestine (Fig. 1A). To investigate cell pro-
liferation and migration along the CVEU, we adminis-
tered a single pulse of BrdU, tracked the distribution of
labeled cells along the CVEU over time, and developed
a mathematical model that quantifies the temporal
dynamics of BrdU labeling or similar thymine analogs
count data for 6 CVEU counts; at least 30 CVEUs were counted per sample. The proportion of labeled cells at each position of
the CVEU was estimated as the average of the scores, 1 or 0, assigned to each position. The crypt–villus boundary was estimated as
the lowest position in the upper part of the crypt at which the proportion of BrdU-labeled cells 2 h after injection is smaller than
0.01. The number of labeled cells in the crypt and on the villus are estimated by summing all labeled cell proportions up to and
beyond, respectively, the crypt–villus boundary. D–G) Proportion of BrdU-labeled cells 2 h after BrdU injection in the duodenum
and ileum of control (D, E) and Omomyc (F, G) mice. Continuous lines show mean values and discontinuous lines SE intervals
estimated from 3–5 animals. Red arrows: crypt–villus boundary. The length of each horizontal axis reﬂects the average measured
length (in cell number) of the CVEU in each tissue and is based on the results presented in Table 1.
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Figure 2. Modeling BrdU labeling in the CVEU, assuming that cell proliferation within the crypt drives migration onto the
villus compartment in control and Omomyc mice. A) Representative images of BrdU labeling progression along the CVEU of
ileum of control mice over 80 h after BrdU injection. B, C) Experimental observations (circles) and 2-compartment model
predictions (lines) of the number of labeled cells over time in the crypt and villus in the duodenum and ileum of control mice.
Filled circles: data points used to ﬁt the model; open circles: data points affected by BrdU cell content dilution resulting from
several successive divisions within the crypt; these points were not used for ﬁtting (C). D) Comparison of net cell production
rates in crypts from duodenum and ileum of control and Omomyc mice. Asterisks indicate statistically signiﬁcant differences.
Statistical inference methods and results can be found in the Theory description and Supplemental Fig. 3E, F) Fit of the
2-compartment model (lines) to the number of labeled cells over time (circles) in the crypt and villus of duodenum and ileum
of Omomyc mice. The root mean square error (RMSE) between predictions and observations is shown for each model ﬁt.
Time 0 is set to 2 h after BrdU administration.
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along the CVEU. This model describes the labeling
process across 2 compartments: the crypt compartment
includes the population of proliferative cells of the
CVEU, as well as nonproliferative cells, both pop-
ulations with numbers we assume to be constant on
average; and the villus compartment, which contains
nonproliferative cells (Fig. 1B). After a single BrdU in-
jection, the model assumes that a proportion of pro-
liferative crypt cells will be labeled. These labeled cells
proliferate, differentiate, migrate, and eventually start
to be transferred to the villus compartment, where they
migrate until they reach the tip of the villus and are shed
into the lumen (for full details, see Theory). Our model
assumes that cell transfer between the crypt and villus is
exclusively related to cell proliferation. This assump-
tion arises naturally when considering that, in our
experimental conditions, the size of the crypt com-
partment maintains a constant value, NC, over time.
Hence, cell proliferation within the crypt is compen-
sated for by the transfer of cells to the villus, and these
processes take place at the same rate. Given that our
CVEU is 1-dimensional, NC is also the length of the
crypt, expressed as the number of cells. By “cell pro-
liferation” or “cell production” we mean the net dif-
ference between cell proliferation and cell death. Our
model also assumes that BrdU cell content is not yet
diluted by successive cell divisions to below the de-
tection limit. To comply with that assumption, the ex-
perimental time was limited so that, in practice, all our
data were collected before the BrdU-labeled front
reached the villus tip. Themodel then admits an explicit
solution, detailed in Eq. 3 of the Theory description,
which we fitted to the counts of BrdU-labeled cells ob-
served in each compartment.
To collect such counts of labeled cells at several times
after a singleBrdU injection,weassigned each cell position
along the CVEU the value 1, if the cell at that location was
labeled with BrdU, or 0, if it was not labeled (Fig. 1C). The
proportion of BrdU-labeled cells at each position of the
CVEUwas estimated as the average of the scores, 1 or 0, at
that cell position for at least 30 CVEUs permouse per time
point.
We first determined the time needed for cell labeling
after a single BrdU injection. Samples collected any
time between 30 min and 2 h after BrdU injection in
control mice yielded similar BrdU labeling profiles
along the ileum CVEU (Supplemental Fig. 1A), in-
dicating that 30–45 min after injection, BrdU was not
available for uptake and that possible cell proliferation
occurringwithin the 2 h period after BrdU injection did
not affect the distribution of labeled cells. We also
verified in Omomyc mice, with reduced cell pro-
liferation, that samples collected 2 and 4 h after BrdU
injection yielded similar BrdU-labeled proportions
(Supplemental Fig. 1B). We concluded that 2 h after a
single-dose BrdU injection constituted an adequate
time 0 in the BrdU labeling process for all mouse
models and tissue samples.
Using the profile of labeled cells along the CVEU ob-
served 2 h after BrdU injection, we next estimated the
position of the boundary between the crypt and villus
compartments. To ensure that all proliferative cells were
contained within the crypt compartment, the boundary
was estimated as the lowest cell position along the CVEU
at which the proportion of BrdU cells observed 2 h after
injection was smaller than an arbitrarily chosen small
number equal to 0.01 (Fig. 1D–G and Table 1). We dem-
onstrated in theTheorydescription andSupplemental Fig.
2 that this position is above practically all proliferative
cells. As the CVEU is a 1-dimensional column of cells, the
position of the crypt–villus boundary coincides with the
size of the crypt compartment NC or the total number of
cells, both proliferative and nonproliferative, within the
crypt.
Once the boundary was established, we calculated
the number of BrdU-labeled cells in the crypt and vil-
lus compartments at each sampling time as the sums of
the proportions of BrdU-labeled cells at all cell posi-
tions below and above the crypt–villus boundary, re-
spectively (Fig. 1C).
Our 2-compartment model was first evaluated on
BrdU-labeled CVEUs of ileum and duodenum of healthy
mice (Fig. 2A–C). Not all data points comply with the re-
quired conditions to fit the model. For example, in the
ileum of control mice (Fig. 2C), we observed that ;40 h
after BrdU injection, the number of BrdU-labeled cells
within the crypt started to decrease, probably because of
the BrdU cell content dilution during successive divisions.
At similar sampling times, the number of BrdU-labeled
cells on the villus reached a maximum constant value,
which is likely to have been caused by cell shedding from
the villus tip. These timings are approximate and specific
for the ileum in control mice and vary, depending on the
length of the CVEU and the population cell kinetics of the
tissue of each strain ofmouse. Because the 2-compartment
model does not account for label dilution, those data
points showing these effects were not used for model fit-
ting (Fig. 2C). Estimated parameter values and associated
errors of model parameters are given in Supplemental
Table 1.
We defined the net cell production rate in the 1-
dimensional CVEU crypt compartment, referred to as
crypt cell production hereafter, by the product d · NC,
where d denotes the specific cell proliferation rate in
ourmathematical model, andNC is the total number of
cells, both proliferative and nonproliferative, within
the crypt. We found that the crypt cell production rate
was ;1.5 cells/h in the duodenum and significantly
lower, about 1 cell/h, in the ileum of healthymice (Fig.
2D and Table 1,). In agreement with these results,
equivalent rates, estimated with S-phase cell labeling
techniques, have been reported to decrease in the distal
direction of the small intestine, from 1.5 to 1 cell/h (2).
Our mathematical model assumes that cell transfer
from the crypt to the villus is related exclusively to cell
proliferation within the crypt. The plausibility of the
fitted parameter values and the agreement between
the model and the data (Fig. 3B, C) indicate that the
proposed hypothesis (i.e., cell proliferation forces cell
migration from the crypt to the villus), represents a
credible explanation for the observed cell dynamics in
these compartments.
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Cell proliferation is reduced in the small
intestinal epithelium of Omomyc mice
Wenext studied cell proliferation andmigration along the
intestinal crypt–villus axis in the TRE-Omomyc;actin-rtTA
double-transgenic mouse, which is reported to exhibit
decreased cell proliferation in multiple tissue sites, in-
cluding the intestine (29). The reduction in cell pro-
liferation in these mice results from inhibition of the
basic helix–loop–helix leucine zipper (bHLHZip) tran-
scription factor Myc, which normally coordinates cel-
lular programs regulating cellular growth, proliferation,
tumorigenesis, and apoptosis. Myc inhibition is medi-
ated by a doxycycline-induced mutant bHLHZip pro-
tein, omomyc, which sequesters and inhibits Myc, in a
dominant-negative fashion (32). Sustained omomyc ex-
pression in the small intestines of these mice, which we
have referred to throughout as Omomyc mice, results in
a reduction in Ki-67 proliferative cell staining in crypts
and significantly blunted villi, yet epithelial integrity is
maintained and there are no apparent effects on apo-
ptosis or differentiation (29).
Expression of Omomyc protein in intestinal crypts was
confirmed by specific antibody staining (Supplemental
Fig. 4), adding to previous reports of Omomyc mRNA
expression in the intestine (29). The total number of BrdU-
labeled cells 2 h after injection was reduced in Omomyc
mice, comparedwith controlmice (Table 1), indicating that
crypt cell proliferation was reduced when Omomyc ex-
pression was induced. To accurately quantify cell pro-
liferation, we fitted the 2-compartment model in Eq. 3 to
the number of BrdU-labeled cells in the crypt and villus
compartments of Omomyc mice observed over time (Fig.
2E, F) fitting results are given in Supplemental Table 1. In
Omomyc mice, we found the crypt cell production rate to
be smaller than in control mice and greater in the duode-
num than in the ileum (Table 1). Although differences
were close to statistically significance at the 95% confi-
dence level (Supplemental Table 3), only the rate in the
duodenum of Omomyc mice was flagged as significantly
slower (0.98 cells/h) than that of control mice (1.5 cells/h)
at that confidence level (Fig. 2D andTable 1). Theobserved
reduction in the crypt proliferation potential makes this
mouse model suitable for studying the impact of cell
proliferation on cell migration on the villus as detailed
below.
Cell proliferation within the crypt and cell
transfer to the villus are temporally halted by
Ara-C administration
Wenext sought toquantify cell dynamics in a systemwith
temporal blockade and resumption of crypt cell pro-
liferation. We assessed the effect of arrested cell pro-
liferation on crypt–villus transfer, using double labeling
with 2 distinct thymine analogs, BrdU and IdU, in mice
treated with the cytostatic/cytotoxic agent Ara-C. With
multiple high doses, Ara-C treatment of rodents is re-
portedly lethal to most or all proliferative intestinal
crypt cells (33–38),whereas at lower doses, proliferative
cells within the crypt exhibit a temporary inhibition of
DNA synthesis and can resume cycling and division
after a matter of hours (39, 40).
Figure 3A shows our experimental strategy, which in-
volved the administration of IdU 17 h before the injection
of a single dose of Ara-C so that the IdU-labeled front had
reached the villi by the time the experimental Ara-C
treatment period commenced. Samples were then col-
lected over the following 57h,with BrdUadministered 1 h
before euthanasia at each sampling time, to monitor any
DNA synthesis within the crypt.
From 1 h after delivery of Ara-C, there was no active
DNA synthesis in the crypt, as reflected by the absence
of BrdU uptake by cells, indicating that Ara-C suc-
cessfully halted cell proliferation. This effect lasted for
at least 10 h (Fig. 3B) and was supported by a dramatic
reduction in the number of mitotic figures, as detected
by anti-phospho-histone H3 (pH3) staining, during this
period (Fig. 3C). A few observed residual mitoses were
attributable to dividing cells that had already com-
pleted the S phase at the time of Ara-C administration.
Cell proliferation was resumed in samples obtained
18 h after Ara-C treatment, in which the proportion and
distribution of cells incorporating BrdU in the cryptwas
similar to that observed in nontreated animals (Fig. 3D)
and the number of pH3-stained cells exhibited a con-
comitant increase (Fig. 3C). In a synchronized fashion,
displacement of the labeled front along the villus, of
both the duodenumand ileum,was detected in samples
collected beyond the first 10 h after Ara-C administra-
tion (Supplemental Fig. 5).
To investigate the effect of crypt cell proliferation
arrest and its recovery on cell transfer to the villus,
we analyzed cell dynamics in 2 distinct periods after
Ara-C administration: during the first 10 h after Ara-C
injection when cell proliferation was arrested; and
afterwards, when proliferation was resumed. To do
this, we fitted the 2-compartment model in Eq. 3 to the
number of BrdU-labeled cells in the crypt and villus
compartments observed during these 2 phases (Fig.
3E–H and Supplemental Table 1). We observed no in-
crease in the number of IdU-labeled cells on the villi of
either duodenum or ileum during the crypt cell pro-
liferation arrest period (Fig. 3E, F). In agreement with
this observation, the fitted cell transfer rates to the
villus were not significantly different from 0 (Table 1).
During the subsequent period of resumed proliferation,
the number of IdU-labeled cells on the villi increased
over time (Fig. 3G, H), resulting in cell transfer rates
similar to those of control mice (Table 1) and crypt
cell production rates not significantly different from
those detected in the ileum and duodenum of control
mice (Fig. 3I). The number of IdU-labeled cells
within crypts maintained a relatively constant value
during both periods of arrested and resumed cell
proliferation (Fig. 3E–H), a result consistent with this
compartment having reached its maximum number
of labeled cells by the time Ara-C was injected. In
summary, we found that epithelial cell transfer from
crypts to villi is halted and resumes in synchrony
with crypt cell proliferation.
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Figure 3. Inhibition of proliferation by treatment with Ara-C. A) Experimental strategy for monitoring migration of IdU-labeled
cells on the villi and cell proliferation within the crypts after Ara-C administration. B) Images of labeled ileum sections at several
(continued on next page)
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Cell proliferation within the crypt is the
principal driving force for cell migration
along the villus
We next explored the hypothesis that cell proliferation
within the crypt drives cell migration along the villus,
by comparing the velocity at which cells migrate out of
the crypt, due to cell proliferation, with the velocity at
which the labeled front migrates along the villus
axis in our homoeostatic-, Omomyc-, and Ara-C-treated
mouse tissues.
As described in the Theory section (Eq. 5), we defined
the velocity, Vx (cells/h meaning average cell lengths/h),
caused bymitotic pressure, of a cell located at anyposition
xwithin the crypt by Vx = d · x, with 1# x# NC, where d
denotes the specific cell proliferation rate in our
2-compartment model, and NC is the crypt–villus bound-
ary. Hence, the velocity of a cell at the crypt–villus bound-
ary can be determined byVC-V = d ·NCwhich is equivalent
to the crypt cell production rate defined above in our
1-dimensional CVEU (Table 1).
The average velocity of cells migrating along the vil-
lus, VLF (in micrometers/hour) was estimated by track-
ing the position of the labeled front, which wemeasured
as the distance in micrometers from the base of the crypt
to the location of the highest BrdU-labeled cell on the
CVEU, over time, (Fig. 4 and Table 1). Our observations
were consistent with the labeled front moving along the
villi at a constant velocity (Fig. 4A–D), which was esti-
mated by linear regression (Eq. 6) as described in the
Theory section and Supplemental Table 1.We found that
cells migrated faster on the villi of the duodenum than
the ileum, and migration was slower in Omomyc mice
than in control mice (Table 1). The cell velocity on the
villus was not significantly different from zero during
the first 10 h after Ara-C administration (Fig. 4E, F and
Table 1) and fully recovered afterward. These results are
consistent with our results regarding the estimated cell
velocities at the crypt–villus boundary generated by
crypt cell proliferation.
We estimated the ratio betweenVC-V andVLF in each
analyzed case, as described in the Theory section, with
the exception of samples collected in the first 10 h after
Ara-C injection where velocities in both the duodenum
and ileumwere not significantly different from 0 (Table 1).
Figure 5 shows that the ratio of these velocitieswas similar
across all analyzed tissues, indicating a tight coupling be-
tween crypt proliferation rates and villus migration rates.
Because of the different distance units between the pa-
rameters VC-V (cell lengths/hour), and VLF (micrometers/
hour), the constant ratio between VC-V and VLF observed
across the tissues is an estimation of the cell density (in
cells/micrometer) of the CVEU. We sought to explore
cell density across the CVEU in greater detail by di-
viding the number of cells in the labeled strip by its
length inmicrometersmeasured at different time points
and therefore for different strip lengths. Our results
indicated that cell density seems to be independent of
spatial position across the CVEU (Supplemental Fig. 6)
with values of about 1 cell/10 mm, relatively large
measurement error and without exhibiting significant
differences among the analyzed tissues (Supplemental
Fig. 6 andTable 1). The observed constant cell density in
the continuous epithelial barrier indicates that cell
length is constant along the CVEU. This result, which
we confirmed by visual inspection, differs from pre-
viously reported observations (4).
The constant ratio between cell velocity at the crypt–
villus boundary and that of the labeled front on the villus
indicated that reduced/increased rates of net crypt cell
production in the duodenum and ileum were met with
proportional reductions/increases in cell migration ve-
locity on the villus in all studied mouse models. These
results support thehypothesis that cell proliferationwithin
the crypt is the principal force driving cellmigration along
the villus.
DISCUSSION
Using a combination of in vivo labeled cell tracking and
mathematical modeling, we have described a method for
precise quantification of cell proliferation and cell migra-
tion in the intestinal epithelium. We use a 2-compartment
model to quantify epithelial cell dynamics in mouse
modelswithdiffering cell proliferationpotential.We show
that in an experimental model of proliferation arrest, mi-
gration ishalteduntil proliferation resumes, andthatvillus
cell migration velocity and crypt cell production rate are
tightly coupled. Altogether, these results strongly suggest
that mitotic pressure is the primary force driving cell
migration along the crypt–villus axis. This hypothesis is
supported by other experimental analyses: increasing
crypt proliferation (using carcinogens, steroids, bacteria,
or genetic alteration) is met by an increase in migration
(41–46), while reducing mitotic rates, by inhibiting
neural activity, results in reduced epithelial migration
(47). However, given other studies that report an ap-
parent “uncoupling” of proliferation and migration
(11–18, 30), we cannot rule out the possibility that some
additional mechanisms, such as active migration and/
or villus contraction and expansion (20–25), may, in
sampling times illustrating that at the time of Ara-C administration, the IdU-labeled cells had already reached the villi, BrdU
uptake was not detected, and mitosis was reduced during the ﬁrst 10 h after Ara-C administration but recovers at later times. C)
Number of mitotic events detected by pH3 staining after Ara-C injection. D) The proportion of crypt cells incorporating BrdU
18 h after Ara-C injection (continuous line) was similar to that observed in nontreated animals (dashed line). E, H) Fit of the
2-compartment model (lines) to observed numbers of labeled cells (circles) in the crypt and villus of mice treated with Ara-C.
Proliferation within the crypt and cell transfer to the villus were blocked during the ﬁrst 10 h after Ara-C administration in
duodenum (E) and ileum (F) and resumed in both tissues at later time points (G, H, respectively). I) Comparison of net cell
production rates in the crypts of control and Ara-C-treated mice. Asterisks: statistically signiﬁcant differences. Statistical inference
methods and results are in the Theory section and Supplemental Fig. 3.
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some cases, affect the tight coupling between cell pro-
liferation and migration along the crypt–villus axis.
In the Ara-C-treated intestines, we did not detect BrdU
uptake and significant cell migration on the villus in our
samples until 18 h after Ara-C treatment (Fig. 2B–D and
Supplemental Fig. 4), indicating that cell proliferation re-
sumed sometime between 10 and 18 h after Ara-C treat-
ment. If we assume that cell proliferation and migration
restarted at the rates observed in the healthy ileum,
0.83cells/hand6.09mm/h, respectively (Table 1), aperiod
of 9.2 h would be required for the BrdU-labeled front to
migrate from the average position at which it was held
during the first 10 h after Ara-C (178 mm), to the position
reached 18 h after treatment once proliferation and
migration resumed (234 mm; Fig. 2F). This calculation
narrows down the prediction for resumption of pro-
liferation and migration to ;10 h after Ara-C and is con-
sistentwith previous studies in rats, where intestinal crypt
cell mitoses were shown to resume around 10–12 h after
Ara-C, before returning to homeostatic levels within
16–24 h after Ara-C treatment (48).
By using cell velocity at the crypt–villus boundary,
which we have demonstrated is coincidental with cell
velocity on the villus, we estimate that the time required
for a cell to migrate from the crypt–villus boundary to the
tip of the villus in healthymice is 49 h in the ileum (where
villus length is equal to 42.5 cells; Table 1), and 60 h in the
duodenum (where the villus length is 80 cells; Table 1).
This compares to ;43 h, for both ileum and duodenum,
calculated by Hagemann and colleagues (49), and 36 and
38 h, respectively, reported in BALB/c mice (16), likely
reflecting methodological or mouse strain variation or
both. To calculate the total time for a cell to migrate from
the base of the crypt to the tip of the villus we need to add
the migration time within the crypt, which can be esti-
mated as described in the Theory section. Under our as-
sumptions, a cell requires on average 92 h tomigrate from
the base of the crypt to the villus tip in the duodenum of
control mice. In Omomyc mice, where proliferation is re-
duced, this time increases to 135 h in theduodenum. In the
ileum,however, villiwere shorter inOmomycmice than in
control animals (52 vs. 61.5 cells from crypt base to villus
tip) resulting in similar calculated transit times for both
mousemodes (97 h inOmomyc vs. 95 h in control) despite
thedecreasedcryptproductionandmigration rates seen in
Omomyc mice.
Our mathematical model is applicable to any in vivo
model of intestinal dynamics in which cells have been
tracked with a label such as a thymine analog or any label
that is transmitted to the progeny in a 2-compartment
system with similar cell dynamics. Such methods can be
Figure 4. Cell migration velocity along the villus. Observed position of the BrdU-labeled front on the CVEU (circles) and its
regression line over time in the duodenum and ileum of control mice (A, B) and Omomyc mice (C, D), 0–10 h after Ara-C
treatment (E, F) and beyond 10 h after Ara-C administration (G, H).
Figure 5. Relationship between cell velocity at the crypt–villus
boundary, VC-V, and cell velocity of the labeled front along the
villus, VLF. The ratio between these velocities was estimated for
control and Omomyc mice and mice in which proliferation
was resumed following Ara-C treatment. Statistically signiﬁcant
differences were not detected between ratios at 95% conﬁ-
dence level.
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used to interrogate epithelial dynamics in in vivo models
and in vitro culture systems in states of perturbed ho-
meostasis and to detect situations in which proliferation
and migration become uncoupled and homeostasis is
lost. For example, thesemethods can be used to determine
the effects on proliferation and migration of conditions
including disease models, pharmacological treatment,
genetic alteration, and altered immune states. This appli-
cation is of particular interest, given that dysregulation or
uncoupling of epithelial proliferation and migration is a
featureofvarioushuman intestinaldisorders. Increased cell
proliferation is one of the early indicators of cancer devel-
opment in the intestine (50), yet precancerous cells migrate
slowly and have increased residence times in the intestine
(51–53). In patients with celiac disease, hyperproliferation
in thecrypts (54) anda lackof compensationon thevilli lead
to ananomalous relationshipbetweenvilli andcrypts anda
denuded epithelium (54). In thiswork,we sought to further
our understanding of the mechanisms underlying the
maintenance of the equilibrium between crypts and villi in
the intestinal epithelium and how this balance is lost and
may be regained after perturbation. A deeper understand-
ing of how these processes maintain the health of the gas-
trointestinal tract will help the development of novel
preventive strategies for pathologic intestinal conditions
such as celiac disease, ulcerative inflammatory processes,
and tumorigenesis.
CONCLUSIONS
In summary, we conclude that cell proliferation within the
crypt is the primary force that drives cell migration along
thevillus. Thepresentedmethods canbeused todetermine
the effects on proliferation and migration of conditions
including disease, pharmacological treatment, genetic al-
teration, and altered immune states, and are of particular
interest in those intestinal disorders characterized by the
uncoupling of cell proliferation and migration.
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Supplemmentary Table 1. Model parameters description, estimates and standard error
Parameter (units) Equation Description Duodenum Ileum Duodenum Ileum Duodenum Ileum Duodenum Ileum
t 0  (h) S3 Initial time (h) 10 10 10 10 115 115 125 125L C 0 (num cells) S3 Number of labelled cells in the crypt at t 0 7.32 ± 1.30 7.64 ± 0.947 4.77 ± 0.763 3.09 ± 0.338 11.6 ± 1.29 9.58 ± 0.302 10.71 ± 1.037 9.25 ± 0.669
L V 0 (num cells) S3 Number of labelled cells on the villus at t 0 10 10 10 10 3.58 ± 0.81 6.35 ± 1.36 5.60 ± 1.12 6.80 ± 0.689
δ (h-1) S3 Crypt specific cell proliferation rate or specific cell transfer rate from crypt to villus 0.0760 ± 0.0147 0.0544 ± 0.00644 0.0547 ± 0.00665 0.0509 ± 0.00427 20.00891 ± 0.0128 20.00136 ± 0.00698 0.0864 ± 0.0144 0.0466 ± 0.00901
t 1  (h) S3 Starting time of labelled cell migration from crypt to villus 6.00 ± 1.52 7.08 ± 2.25 14.0 ± 1.43 18.6 ± 0.476 115 115 125 125
V LF (µm/h) S6 Velocity of labelled front on villus 9.00 ± 0.465 5.96 ± 0.379 7.24 ± 0.190 5.29 ± 0.235 2-0.798 ± 0.942 20.0765 ± 0.477 8.68 ± 0.655 6.09 ± 1.15K (µm) S6 Arbitrary constant 3.28 ± 9.86 86.3 ± 7.54 -25.3 ± 7.21 8.41 ± 8.04 193 ± 17.6 179 ± 9.83 -66.7 ± 27.2 19.9 ± 44.0
1 Fixed value. 
2 Not significantly different from 0
Time 0 set to time of label activation (2h post-label injection)
Control Omomyc 3Within [0-10h] post-AraC 4Beyond 10h post-AraC
